Résumé
La dérivation porto-systémique est le traitement le plus efficace des complications de l’hypertension portale. Toutefois, les techniques chirurgicales ont été quasiment abandonnées en raison des taux élevés de mortalité et d’encéphalopathie; elles sont réservées aux rares patients à la fonction hépatique parfaitement conservée. Dans les années 1990, la dérivation porto-systémique a retrouvé sa place dans l’arsenal thérapeutique de l’hypertension portale grâce au développement de son équivalent par radiologie interventionnelle: le TIPS (transjugular intrahepatic portosystemic shunt). L’abord transjugulaire du foie avait été mis au point initialement par Hanafee et Weiner dans le cadre de la réalisation de phlébographies, de cholangiographies et de biopsies hépatiques. Le premier shunt porto-systémique intrahépatique a été créé chez le porc en 1969 par J. Rösch et al. [1].
INSERM U 858 I2MR (Institut de médecine moléculaire de Rangueil) Équipe X (Athérosclérose et artériosclérose de greffe)
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Références
Rosch J, Hanafee WN, Snow H (1969). Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 92(5):1112–4
Colapinto RF, Stronell RD, Gildiner M et al. (1983). Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol 140(4):709–14
Palmaz JC, Sibbitt RR, Reuter SR et al. (1985) Expandable intrahepatic portacaval shunt stents: early experience in the dog. AJR Am J Roentgenol 145(4): 821–5
Richter GM, Noeldge G, Palmaz JC et al. (1990). Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 174(3 Pt 2): 1027–30
Bureau C, Garcia-Pagan JC, Otal P et al. (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126(2): 469–75
Semba CP, Saperstein L, Nyman U, Dake MD (1996) Hepatic laceration from wedged venography performed before transjugular intrahepatic portosystemic shunt placement. J Vasc Interv Radiol 7(1): 143–6
Krajina A, Lojik M, Chovanec V, Raupach J, Hulek P (2002) Wedged hepatic venography for targeting the portal vein during TIPS: comparison of carbon dioxide and iodinated contrast agents. Cardiovasc Intervent Radiol 25(3): 171–5
Soares GM, Murphy TP (1999) Transcaval TIPS: indications and anatomic considerations. J Vasc Interv Radiol 10(9): 1233–8
Blum U, Haag K, Rossle M et al. (1995) Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 195(1):153–7
Han G, Qi X, He C et al. (2011). Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 54(1): 78–88
Barton RE SR, Lakin PC, Petersen BD, Keller FS (1995) TIPS: short-and long-term results: a survey of 1750 patients. Sem Interv Radiol 364–7
Malinchoc M, Kamath PS, Gordon FD et al. (2000). A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4):864–71
Salerno F, Camma C, Enea M et al. (2007). Transjugular intrahepatic portosystemic shunt for refractory ascites: a metaanalysis of individual patient data. Gastroenterology 133(3): 825–34
Rossle M, Siegerstetter V, Huber M, Ochs A (1998). The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 18(2): 73–89
Bureau C, Otal P, Chabbert V, Peron JM et al. (2002). Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent. Hepatology 36(6): 1554
Vizzutti F, Arena U, Rega L et al. (2009). Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. Gut 58(4): 582–4
Ducoin H, El-Khoury J, Rousseau H et al. (1997). Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 25(5): 1064–9
Casado M, Bosch J, Garcia-Pagan JC et al. (1998). Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114(6): 1296–303
Owens CA, Bartolone C, Warner DL et al. (1998) The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 114(5): 975–80
Bureau C, Pagan JC, Layrargues GP, et al. (2007). Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 27(6): 742–7
Otal P, Smayra T, Bureau C et al. (2002) Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol 178(1):141–7
Papatheodoridis GV, Goulis J, Leandro G et al. (1999). Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology 30(3): 612–22
Maleux G, Heye S, Verslype C, Nevens F (2007) Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study. J Vasc Interv Radiol 18(8): 986–92; quiz 93
Riggio O, Ridola L, Angeloni S et al. (2010) Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 53(2): 267–72
Sanyal AJ, Reddy KR (1998) Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 115(1): 110–5
Sanyal AJ, Freedman AM, Purdum PP 3rd (1992). TIPS-associated hemolysis and encephalopathy. Ann Intern Med 117(5): 443–4
Chau TN, Patch D, Chan YW et al. (1998) «Salvage» transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114(5): 981–7
Sanyal AJ, Freedman AM, Luketic VA et al. (1996). Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 111(1): 138–46
Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L et al. (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40(4): 793–801
Garcia-Pagan JC, Caca K, Bureau C et al. (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362(25): 2370–9
Burroughs AK, Vangeli M (2002) Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 37(3): 249–52
Henderson JM, Boyer TD, Kutner MH et al. (2006). Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 130(6): 1643–51
Boyer TD, Henderson JM, Heerey AM et al. (2008) Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 48(3): 407–14
Lebrec D, Vinel JP, Dupas JL (2005). Complications of portal hypertension in adults: a French consensus. Eur J Gastroenterol Hepatol 17(4): 403–10
D’Amico G, Luca A, Morabito A et al. (2005). Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 129(4): 1282–93
Saab S, Nieto JM, Lewis SK, Runyon BA (2006) TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev (4) CD004889
Brensing KA, Textor J, Perz J et al. (2000) Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47(2): 288–95
Gordon FD, Anastopoulos HT, Crenshaw W et al. (1997) The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 5(6): 1366–9
Peron JM, Dupuis E, Alric L et al. (1999) [Treatment by portosystemic intrahepatic shunt for refractory hydrothorax during cirrhosis]. Gastroenterol Clin Biol 3(3): 414–5
Hernandez-Guerra M, Turnes J, Rubinstein P et al. (2004) PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 40(5): 1197–202
Plessier A, Sibert A, Consigny Y et al. (2006) Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 44(5): 1308–16
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Otal, P., Bureau, C., Lagarde, S., Mokrane, T., Vinel, JP., Rousseau, H. (2013). TIPS. In: Thérapeutiques endovasculaires des pathologies veineuses. Springer, Paris. https://doi.org/10.1007/978-2-8178-0291-6_25
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0291-6_25
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0290-9
Online ISBN: 978-2-8178-0291-6
eBook Packages: MedicineMedicine (R0)